Theralase Technologies Inc. ( #TSXV: $TLT | #OTCQB: #TLTFF ) CEO Roger White said interim Phase II data showed two-thirds of bladder cancer patients who failed standard care had their cancer destroyed after one treatment. How long did it last?
Watch: youtu.be/sb-_w3PoR_k?...
